Budelite F 100mcg Capsule 30's

The Budelite F 100mcg Capsule is a pharmaceutical product engineered for the effective management of chronic obstructive pulmonary disease (COPD) and asthma. This medication integrates two active pharmaceutical ingredients: Formoterol Fumarate Dihydrate, a long-acting beta2-adrenergic agonist (LABA), and Budesonide, an inhaled corticosteroid (ICS). This synergistic formulation provides comprehensive respiratory support by addressing both bronchoconstriction and airway inflammation, making breathing easier for patients.

Utilizing dry powder inhalation (DPI) technology, Budelite F 100mcg Capsules are administered via a specialized inhaler device, commonly referred to as Rotacaps. This delivery method ensures targeted and efficient deposition of the medication directly into the lungs, maximizing therapeutic effect while minimizing systemic exposure. It is intended for long-term maintenance treatment to improve lung function and reduce the frequency and severity of exacerbations in patients whose condition is not adequately controlled by a single long-term asthma-control medication.

This combination therapy is crucial for healthcare settings requiring reliable and effective solutions for chronic respiratory conditions. It aids in maintaining stable breathing patterns and enhancing the overall quality of life for patients with persistent asthma and COPD.

Key Features : 

Dual-action formulation with Formoterol Fumarate Dihydrate (6 mcg) and Budesonide (100 mcg)
Designed for dry powder inhalation (DPI) via Rotacaps
Provides long-acting bronchodilation to relax airway muscles
Contains an inhaled corticosteroid to reduce airway inflammation
Indicated for the long-term maintenance treatment of asthma and COPD
Aids in improving lung function and preventing exacerbations